The genetics of multiple sclerosis: SNPs to pathways to pathogenesis
The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis (MS) is an autoimmune demyelinating disease and a common cause of neurological disability in young adults. The modest heritability of MS reflects complex genetic effects and multifaceted gene-environment interactions. The human leukocyte antigen (HLA) region is the strongest susceptibility locus for MS, but a genome-wide association study recently identified new susceptibility genes. Progress in high-throughput genotyping and sequencing technologies and a better understanding of the structural organization of the human genome, together with powerful brain-imaging techniques that refine the phenotype, suggest that the tools could finally exist to identify the full set of genes influencing the pathogenesis of MS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“do not seem to have a significant genetic component”
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Network biology: understanding the cell's functional organization
Barabási, A.-L., & Oltvai, Z. N. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1272 · Cited by 7,903
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
The Future of Genetic Studies of Complex Human Diseases
Risch, N., & Merikangas, K. (1996) · Science · doi:10.1126/science.273.5281.1516 · Cited by 5,355
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439 · cited 1×
“It is of considerable interest that a recent clinical trial of an anti-B-cell therapy in MS showed marked effects in reducing bursts of focal inflammatory disease activity, establishing the vital importance of B cells as triggers of MS attack”
BackgroundSelf-citationWacholder, S., Chanock, S., Garcia-Closas, M., El ghormli, L., & Rothman, N. (2004) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djh075 · Cited by 1,754
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746
Research works printed but not linked: 3
- Hauser, S. L. & Goodin, D. S. in Harrison's Principle of Internal Medicine 17th edn (eds Fauci, A. D. et al.) 2611–2620 (McGraw Hill, New York, 2008).
- Kantarci, O. H. et al. Men with MS transmit the disease more often to their children then women: the Carter effect. Mult. Scler. 10, S203 (2004).
- Anderson, A. & Karlsson J. Genetic of experimental autoimmune encephalomyelitis in the mouse. Arch. Immunol. Ther. Exp. (Warz) 52, 316–325 (2004).
Cited by
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
Alterations of the human gut microbiome in multiple sclerosis
Jangi, S., Gandhi, R., Cox, L. M., Li, N., von Glehn, F., Yan, R., Patel, B., Mazzola, M. A., Liu, S., Glanz, B. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12015 · Cited by 1,307
Common variants on chromosome 6p22.1 are associated with schizophrenia
Shi, J., Levinson, D. F., Duan, J., Sanders, A. R., Zheng, Y., Pe’er, I., Dudbridge, F., Holmans, P. A., Whittemore, A. S., Mowry, B. J., et al. (2009) · Nature · doi:10.1038/nature08192 · Cited by 1,170
Self-citationThe HLA genomic loci map: expression, interaction, diversity and disease
Shiina, T., Hosomichi, K., Inoko, H., & Kulski, J. K. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2008.5 · Cited by 782
Kappos, L., Li, D., Calabresi, P. A., O'Connor, P., Bar-Or, A., Barkhof, F., Yin, M., Leppert, D., Glanzman, R., Tinbergen, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61649-8 · Cited by 743
Self-citationMultiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy.
Ghasemi, N., Razavi, S., & Nikzad, E. (2016) · PubMed · doi:10.22074/cellj.2016.4867 · Cited by 685
“In all individuals who have 50% genetic similarities such as dizygotic twins and first degree relatives, this risk is 2-5% (51, 52).”
BackgroundB cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
Barr, T. A., Shen, P., Brown, S., Lampropoulou, V., Roch, T., Lawrie, S., Fan, B., O’Connor, R. A., Anderton, S. M., Bar-Or, A., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111675 · Cited by 649
“Although polymorphisms in genes controlling T cell activation show the strongest association with disease susceptibility (Oksenberg et al., 2008), B cell activation is also a common abnormality in RR-MS, highlighted by the presence of intrathecal oligoclonal immunoglobulin bands in >90% of patients…”
BackgroundEpigenetic mechanisms in neurological diseases: genes, syndromes, and therapies
Urdinguio, R. G., Sanchez-Mut, J. V., & Esteller, M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70262-5 · Cited by 582
Sex and gender issues in multiple sclerosis
Harbo, H. F., Gold, R., & Tintoré, M. (2013) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285613488434 · Cited by 529
Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis
Baranzini, S. E., Mudge, J., van Velkinburgh, J. C., Khankhanian, P., Khrebtukova, I., Miller, N. A., Zhang, L., Farmer, A. D., Bell, C. J., Kim, R. W., et al. (2010) · Nature · doi:10.1038/nature08990 · Cited by 476
Self-citationNOX Enzymes in the Central Nervous System: From Signaling to Disease
Sorce, S., & Krause, K.-H. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2578 · Cited by 471
A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury
Singer, J. B., Lewitzky, S., Leroy, E., Yang, F., Zhao, X., Klickstein, L., Wright, T. M., Meyer, J., & Paulding, C. A. (2010) · Nature Genetics · doi:10.1038/ng.632 · Cited by 388
Risk factors for and management of cognitive dysfunction in multiple sclerosis
Benedict, R. H. B., & Zivadinov, R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.61 · Cited by 370
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“While its underlying causes remain uncertain, and do not seem to have a significant genetic component (Baranzini et al. 2010; Oksenberg et al. 2008; Ramagopalan et al. 2008), ROS are certainly implicated (Adibhatla and Hatcher 2010), and antioxidant therapies may be useful (Mirshafiey and…”
BackgroundMicroglia-Mediated Inflammation and Neurodegenerative Disease
Xu, L., He, D., & Bai, Y. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9593-4 · Cited by 332
“Some studies have shown that immune cytokine and its receptor directly involved in the pathological process of demyelination [41, 42].”
BackgroundAutoimmune diseases: insights from genome-wide association studies
Lettre, G., & Rioux, J. D. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn246 · Cited by 317
The genetics and epigenetics of autoimmune diseases
Hewagama, A., & Richardson, B. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.03.007 · Cited by 302
“Epstein–Barr virus (EBV) infection has also been implicated in the inflammatory response in MS [73].”
The Role of Genetics in the Etiology of Schizophrenia
Gejman, P. V., Sanders, A. R., & Duan, J. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.12.003 · Cited by 296
“1 FAM69A-EVI-RPL5 gene cluster,(89) which has been implicated in multiple sclerosis.(120)”
Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients
Palanichamy, A., Jahn, S., Nickles, D., Derstine, M., Abounasr, A., Hauser, S. L., Baranzini, S. E., Leppert, D., & von Büdingen, H.-C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400118 · Cited by 289
Self-citationTwin studies in autoimmune disease: Genetics, gender and environment
Bogdanos, D. P., Smyk, D. S., Rigopoulou, E. I., Mytilinaiou, M. G., Heneghan, M. A., Selmi, C., & Eric Gershwin, M. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.11.003 · Cited by 271
HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis
Wang, J., Jelcic, I., Mühlenbruch, L., Haunerdinger, V., Toussaint, N. C., Zhao, Y., Cruciani, C., Faigle, W., Naghavian, R., Foege, M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.054 · Cited by 268
Is multiple sclerosis a mitochondrial disease?
Mao, P., & Reddy, P. H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.07.002 · Cited by 243
“The HLA-DRB1⁎1501 molecule may explain about 50% of MS cases.”
BackgroundJacob, C. O., Zhu, J., Armstrong, D. L., Yan, M., Han, J., Zhou, X. J., Thomas, J. A., Reiff, A., Myones, B. L., Ojwang, J. O., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901181106 · Cited by 240
Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity
Guerau-de-Arellano, M., Smith, K. M., Godlewski, J., Liu, Y., Winger, R., Lawler, S. E., Whitacre, C. C., Racke, M. K., & Lovett-Racke, A. E. (2011) · Brain · doi:10.1093/brain/awr262 · Cited by 188
Overcoming remyelination failure in multiple sclerosis and other myelin disorders
Fancy, S. P. J., Kotter, M. R., Harrington, E. P., Huang, J. K., Zhao, C., Rowitch, D. H., & Franklin, R. J. M. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.12.020 · Cited by 192
The epigenetics of autoimmunity
Meda, F., Folci, M., Baccarelli, A., & Selmi, C. (2011) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.78 · Cited by 193
The pursuit of genome-wide association studies: where are we now?
Ku, C. S., Loy, E. Y., Pawitan, Y., & Chia, K. S. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.19 · Cited by 180
Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells
Hartmann, F. J., Khademi, M., Aram, J., Ammann, S., Kockum, I., Constantinescu, C., Gran, B., Piehl, F., Olsson, T., Codarri, L., et al. (2014) · Nature Communications · doi:10.1038/ncomms6056 · Cited by 166
The genetics of autoimmune diseases: a networked perspective
Baranzini, S. E. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.09.014 · Cited by 160
“The large number of common genetic variation in the human population means that prior odds that a randomly chosen marker is relevant for a given disease are extremely low (estimated at 10 5 for MS [8]).”
BackgroundSelf-citationSerafini, B., Severa, M., Columba-Cabezas, S., Rosicarelli, B., Veroni, C., Chiappetta, G., Magliozzi, R., Reynolds, R., Coccia, E. M., & Aloisi, F. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181e332ec · Cited by 161
Correale, J. D., Ysrraelit, M. C., & Gaitán, M. I. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000588 · Cited by 175
“thought to result from the action of common allelic variants in several genes (4).”
BackgroundSecher, T., Kassem, S., Benamar, M., Bernard, I., Boury, M., Barreau, F., Oswald, E., & Saoudi, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01096 · Cited by 148
Dara, L., Liu, Z., & Kaplowitz, N. (2016) · Liver International · doi:10.1111/liv.12988 · Cited by 127
“Four alleles were highly associated with toxicity, and interestingly these alleles lie on a common haplotype (HLA-DRB1*1501HLA-DQB1*0602-HLA-DRB5*0101-HLADQA1*0102) that has been associated with multiple sclerosis (39, 40).”
BackgroundGandhi, K. S., McKay, F. C., Cox, M., Riveros, C., Armstrong, N., Heard, R. N., Vucic, S., Williams, D. W., Stankovich, J., Brown, M., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq090 · Cited by 138
“Extensive studies of population genetics have shown a major genetic component to the disease (1).”
BackgroundModelling Genetic Susceptibility to Multiple Sclerosis with Family Data
O’Gorman, C., Lin, R., Stankovich, J., & Broadley, S. (2012) · Neuroepidemiology · doi:10.1159/000341902 · Cited by 175
Maranduba, C. M. D. C., De Castro, S. B. R., Souza, G. T. D., Rossato, C., da Guia, F. C., Valente, M. A. S., Rettore, J. V. P., Maranduba, C. P., Souza, C. M. D., Carmo, A. M. R. D., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/931574 · Cited by 134
“Further studies are still needed in order to clarify the interaction between gut microbiota and neuroimmune system, as well as with endocrine system, so as to create nutrigenetic profiles that may aid in reaching individual homeostasis.”
BackgroundMultiple sclerosis genetics—is the glass half full, or half empty?
Oksenberg, J. R., & Baranzini, S. E. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.91 · Cited by 161
Self-citationPathogenesis of Immunoglobulin A Nephropathy: Recent Insight from Genetic Studies
Kiryluk, K., Novák, J., & Gharavi, A. G. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-041811-142014 · Cited by 133
“The DRB1*1501-DQB1*0602 haplotype is common in the European and Asian populations and has been implicated in the risk of multiple disorders of immunity and response to environment: it has been associated with increased risk of multiple sclerosis (54), systemic lupus erythematosus (55), narcolepsy (56), and hepatotoxic…”
BackgroundMultiple sclerosis susceptibility alleles in African Americans
Johnson, B. A., Wang, J., Taylor, E. M., Caillier, S. J., Herbert, J., Khan, O. A., Cross, A. H., Jager, P. L. D., Gourraud, P., Cree, B., et al. (2009) · Genes and Immunity · doi:10.1038/gene.2009.81 · Cited by 132
“3, but also indicated a polygenic mode of inheritance with each non-MHC gene contributing only a modest effect to the overall risk”
BackgroundSelf-citationEpstein–Barr virus and multiple sclerosis
Salvetti, M., Giovannoni, G., & Aloisi, F. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32832b4c8d · Cited by 126
Genetic Association and Altered Gene Expression of Mir-155 in Multiple Sclerosis Patients
Paraboschi, E. M., Soldà, G., Gemmati, D., Orioli, E., Zeri, G., Benedetti, M. D., Salviati, A., Barizzone, N., Leone, M., Duga, S., et al. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12128695 · Cited by 102
Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes
Martinelli, V., Dalla Costa, G., Colombo, B., Dalla Libera, D., Rubinacci, A., Filippi, M., Furlan, R., & Comi, G. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458513494959 · Cited by 118
“20(2) 147 –155 © The Author(s) 2013 Reprints and permissions: sagepub.”
Molecular mechanisms of HLA association with autoimmune diseases
Caillat‐Zucman, S. (2008) · Tissue Antigens · doi:10.1111/j.1399-0039.2008.01167.x · Cited by 142
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility
Couturier, N., Bucciarelli, F., Nurtdinov, R. N., Debouverie, M., Lebrun-Frenay, C., Defer, G., Moreau, T., Confavreux, C., Vukusic, S., Cournu-Rebeix, I., et al. (2011) · Brain · doi:10.1093/brain/awr010 · Cited by 112
Self-citationReview part 2: Human herpesvirus‐6 in central nervous system diseases
Yao, K., Crawford, J. R., Komaroff, A. L., Ablashi, D. V., & Jacobson, S. (2010) · Journal of Medical Virology · doi:10.1002/jmv.21861 · Cited by 107
“Alternatively, host genetics and immune status may also, in part, influence the severity and clinical manifestations of virus-induced pathology [Oksenberg et al., 2008].”
BackgroundFrom genes to function: the next challenge to understanding multiple sclerosis
Fugger, L. H., Friese, M. A., & Bell, J. I. (2009) · Nature reviews. Immunology · doi:10.1038/nri2554 · Cited by 129
“The MHC region is by far the most important genetic region and confers a much greater risk of multiple sclerosis development than all other known loci combine”
BackgroundFitzner, D., & Simons, M. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246218 · Cited by 103
“Furthermore, new genetic approaches such as genomewide association scans for MS have recently identified new susceptibility loci for MS [25-27].”
BackgroundThe Gut Microbiome in Multiple Sclerosis
Mielcarz, D. W., & Kasper, L. H. (2015) · Current Treatment Options in Neurology · doi:10.1007/s11940-015-0344-7 · Cited by 115
Intrathecal immune responses to EBV in early MS
Jaquiéry, E., Jilek, S., Schluep, M., Meylan, P., Lysandropoulos, A., Pantaleo, G., & Du Pasquier, R. A. (2010) · European Journal of Immunology · doi:10.1002/eji.200939761 · Cited by 101
Correale, J., & Farez, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900897 · Cited by 99
Genetics and pathogenesis of multiple sclerosis
Zuvich, R. L., McCauley, J. L., Pericak‐Vance, M. A., & Haines, J. L. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.08.003 · Cited by 125
HLA-B62 and HLA-DQ8 are associated with Complex Regional Pain Syndrome with fixed dystonia
A, A. M. D. R., Gosso, F. M., Haasnoot, G. W., Marinus, J., Verduijn, W., Claas, F. H. J., van den Maagdenberg, A. M. J. M., & van Hilten, J. J. (2009) · Pain · doi:10.1016/j.pain.2009.05.015 · Cited by 109
“MHC gene variations confer susceptibility to a variety of inflammatory disorders such as celiac disease and multiple sclerosis [22,36].”
Correale, J. D., & Gaitán, M. I. (2015) · Acta Neurologica Scandinavica · doi:10.1111/ane.12431 · Cited by 106
“Individual genes, however, appear to contribute little to overall risk, and MHC remains the key susceptibility locus for MS (2, 3).”
BackgroundAggregation of multiple sclerosis genetic risk variants in multiple and single case families
Gourraud, P., McElroy, J. P., Caillier, S. J., Johnson, B. A., Santaniello, A., Hauser, S. L., & Oksenberg, J. R. (2011) · Annals of Neurology · doi:10.1002/ana.22323 · Cited by 110
“Multiple sclerosis (MS) is a severe disease of the central nervous system and common cause of neurological disability in young adults.(1,2) MS displays several characteristics that are common to numerous autoimmune diseases, including moderate polygenic heritability, evidence of environmental exposure, clinical and ge…”
BackgroundSelf-citationMethylation patterns of cell-free plasma DNA in relapsing–remitting multiple sclerosis
Liggett, T., Melnikov, A. A., Tilwalli, S., Yi, Q., Chen, H., Replogle, C., Feng, X., Reder, A. T., Stefoski, D., Balabanov, R., et al. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.12.018 · Cited by 108
“New, high throughput technologies have also been used for biomarker research [12].”
Dickinson, J. L., Perera, D., van der Mei, I. A. F., Ponsonby, A., Polanowski, A. M., Thomson, R. J., Taylor, B. V., McKay, J., Stankovich, J. M., & Dwyer, T. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509102459 · Cited by 95
“The HLA-DR15 locus remains the strongest susceptibility locus associated with MS risk [36], and this is true for this dataset (OR3.”
BackgroundBashinskaya, V. V., Кулакова, О. Г., Boyko, A. N., Favorov, A. V., & Favorova, O. O. (2015) · Human Genetics · doi:10.1007/s00439-015-1601-2 · Cited by 110
“A genotypic gradient of risk with ascending hierarchy from DRB1*11:01/DRB1*11:01 up to DRB1*15:01/DRB1*15:01 has been described (Oksenberg et al. 2008).”
BackgroundMartin, D., Pantoja, C., Miñán, A. F., Valdes-Quezada, C., Moltó, E., Matesanz, F., Bogdanović, O., de la Calle-Mustienes, E., Domínguez, O., Taher, L., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2059 · Cited by 91
“Pathogenetically, multiple sclerosis is an autoimmune disease leading to the demyelination of central nervous system (CNS) axon”
BackgroundNew approaches in the management of multiple sclerosis
Allington, D. R. (2010) · Drug Design Development and Therapy · doi:10.2147/dddt.s9331 · Cited by 114
“Oksenberg and colleagues have published an excellent review of this topic.(27) Data mining of extensive brain plaque libraries from MS patients, compared to data from normal controls, have yielded other important areas of investigation.”
Kofler, D. M., Severson, C. A., Mousissian, N., De Jager, P. L., & Hafler, D. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100626 · Cited by 89
“Moreover, siblings of affected individuals exhibit a 15–20% increased relative risk for development of MS (37).”
BackgroundTranscriptome study of differential expression in schizophrenia
Sanders, A. R., Göring, H. H. H., Duan, J., Drigalenko, E. I., Moy, W., Freda, J., He, D., Shi, J., & Gejman, P. V. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt350 · Cited by 88
The gut microbiome and microbial translocation in multiple sclerosis
Mirza, A., & Mao‐Draayer, Y. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.03.001 · Cited by 97
The genetics of multiple sclerosis: An update 2010
Hoffjan, S., & Akkad, D. A. (2010) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2010.04.006 · Cited by 97
“Gene/gene interactions (so-called epistatic effects) are also believed to play an important role for the pathogenesis of complex diseases [1].”
BackgroundInfluentialAxonal loss in multiple sclerosis
Criste, G. A., Trapp, B. D., & Dutta, R. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52001-2.00005-4 · Cited by 110
EBV induces CNS homing of B cells attracting inflammatory T cells
Läderach, F., Piteros, I., Fennell, É., Bremer, E., Last, M., Schmid, S., Rieble, L., Campbell, C., Ludwig-Portugall, I., Bornemann, L., et al. (2025) · Nature · doi:10.1038/s41586-025-09378-0 · Cited by 81
Multiple sclerosis: doubling down on MHC
Martinꝉ, R., Sospedra, M., EIERMANN, T. H., & Olsson, T. P. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.04.012 · Cited by 90
“The HLA-DR15 haplotype contributes by far the most to the genetic risk of Caucasoid MS patients, with estimates reaching up to 60% [25].”
The applications of anti-CD20 antibodies to treat various B cells disorders
Payandeh, Z., Bahrami, A. A., Hoseinpoor, R., Mortazavi, Y., Rajabibazl, M., Rahimpour, A., Taromchi, A. H., & Khalil, S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.121 · Cited by 86
The Pathogenic Role of Dysregulated Epigenetic Modifications in Autoimmune Diseases
Wu, H., Chen, Y., Zhu, H., Zhao, M., & Lu, Q. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02305 · Cited by 84
Pediatric multiple sclerosis – current status of epidemiology, diagnosis and treatment
Brola, W., & Steinborn, B. (2020) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2020.0069 · Cited by 79
Gobert, R. P., Joubert, L., Curchod, M., Salvat, C., Foucault, I., Jorand‐Lebrun, C., Lamarine, M., Peixoto, H., Vignaud, C., Frémaux, C., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01375-08 · Cited by 78
“From population genetic surveys thus far, only a few genes have been found to be associated with multiple sclerosis (31).”
BackgroundWu, H., Zhao, M., Yoshimura, A., Chang, C., & Lu, Q. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8534-y · Cited by 71
“, abnormal gene expression has been observed in RA synovial fibroblasts (RASF) without genetic mutations, suggesting the involvement of epigenetic modifications [11], and sunlight, Epstein-Barr virus (EBV) infection [12, 13], and miRNAs [14, 15] have been implicated in the pathogenesis of MS.”
BackgroundHuang, J., & Xie, Z.-F. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.09.024 · Cited by 70
“Linkage and association studies have found that the human leukocyte antigen (HLA) region is the strongest susceptibility locus for MS, but it does not completely explain the genetic impact on disease susceptibility [9].”
BackgroundEffects of Natalizumab Treatment on the Cerebrospinal Fluid Proteome of Multiple Sclerosis Patients
Stoop, M. P., Singh, V. P., Stingl, C., Martinꝉ, R., Khademi, M., Olsson, T. P., Hintzen, R. Q., & Luider, T. M. (2013) · Journal of Proteome Research · doi:10.1021/pr3012107 · Cited by 68
Multiple sclerosis and obesity: The role of adipokines
Correale, J. D., & Marrodán, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1038393 · Cited by 79
Epigenetic Modifications and Therapy in Multiple Sclerosis
Aslani, S., Jafari, N., Javan, M. R., Karami, J., Ahmadi, M., & Jafarnejad, M. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8422-x · Cited by 87
“2007), have not been satisfying to introduce genes that are in a significant association with susceptibility to MS (Oksenberg et al. 2008; Akkad et al. 2009).”
BackgroundDoes the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology?
Adamczyk-Sowa, M., Medrek, A., Madej, P., Michlicka, W., & Dobrakowski, P. (2017) · Journal of Immunology Research · doi:10.1155/2017/7904821 · Cited by 67
Decoding multiple sclerosis: an update on genomics and future directions
Oksenberg, J. R. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.865867 · Cited by 71
Self-citationInfluence of the HLA-DRB1 Genotype on Antibody Development to Interferon Beta in Multiple Sclerosis
Buck, D., Cepok, S., Hoffman, S., Grummel, V., Jochim, A., Berthele, A., Hartung, H., Waßmuth, R., & Hemmer, B. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.65 · Cited by 67
Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data
Wang, J. H., Pappas, D., De Jager, P. L., Pelletier, D., de Bakker, P. I., Kappos, L., Polman, C. H., Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), Chibnik, L. B., Hafler, D. A., et al. (2011) · Genome Medicine · doi:10.1186/gm217 · Cited by 66
“Extensive epidemiological and laboratory data indicate that genetic susceptibility is an important determinant of MS risk [1,2]; this risk is modulated by family history, ancestry, gender, age, and geography [3].”
BackgroundSelf-citationTargeting dendritic cells to treat multiple sclerosis
Comabella, M., Montalban, X., Münz, C., & Lünemann, J. D. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.112 · Cited by 64
Virus expanded regulatory T cells control disease severity in the Theiler’s virus mouse model of MS
Richards, M. H., Getts, M. T., Podojil, J. R., Jin, Y.-H., Kim, B. S., & Miller, S. D. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.12.005 · Cited by 63
“Numerous genes have been linked to MS disease susceptibility with MHC genes being the most strongly associated with disease [3,4].”
BackgroundKiller immunoglobulin‐like receptor ligand HLA‐Bw4 protects against multiple sclerosis
Lorentzen, Å. R., Karlsen, T. H., Olsson, M., Smestad, C., Mero, I., Woldseth, B., Sun, J., Senitzer, D., Celius, E. G., Thorsby, E., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21695 · Cited by 71
“Later, it was shown that these HLA class I associations were most likely due to linkage disequilibrium (LD) with the HLA-DRB1*1501-DQB1*0602 haplotype.(3,4) Recently, there has been a renewed interest in the role of genes in the HLA class I region in MS, and HLA class II independent associations have now been reported…”
BackgroundMultiple Sclerosis is Not a Disease of the Immune System
Corthals, A. P. (2011) · The Quarterly Review of Biology · doi:10.1086/662453 · Cited by 60
“…lack of sunlight reduces UV-linked Vitamin D synthesis with immune system regulation (Poser 1994; Rosati 2001; VanAmerongen et al. 2004; Broadley 2007; Oksenberg et al. 2008; Ascherio et al. 2010; Comabella et al. 2010; Grant 2010; Simon et al. 2010; van der Mei et al. 2011; Wang et al. 2011).”
BackgroundSanders, A. R., Drigalenko, E. I., Duan, J., Moy, W., Freda, J., Göring, H. H. H., Gejman, P. V., & on behalf of, M. G. S. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.47 · Cited by 64
Dissecting Mechanisms of Myelinated Axon Formation Using Zebrafish
Czopka, T., & Lyons, D. A. (2011) · Methods in cell biology · doi:10.1016/b978-0-12-381320-6.00002-3 · Cited by 69
“MS results from a multitude of genetic and environmental factors, each of which is likely to contribute in varying degrees to disease susceptibility (Handel et al., 2010; Oksenberg et al., 2008; Sawcer, 2008).”
BackgroundWeber, F., Cepok, S., Wolf, C., Berthele, A., Uhr, M., Bettecken, T., Buck, D., Hartung, H., Holsboer, F., Müller‐Myhsok, B., et al. (2011) · The Pharmacogenomics Journal · doi:10.1038/tpj.2011.14 · Cited by 59
Myelin Regeneration in Multiple Sclerosis: Targeting Endogenous Stem Cells
Huang, J. K., Fancy, S. P. J., Zhao, C., Rowitch, D. H., ffrench‐Constant, C., & Franklin, R. J. M. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0065-x · Cited by 64
“MS research for many decades has resulted in a considerable investment into the immunological aspects of the disease, as reflected in the identification of several immune-related genes as genetic determinants of disease susceptibility [6] and an understanding of the disease pathogenesis [1, 7].”
BackgroundGenome-Wide Analysis Reveals Novel Regulators of Growth in Drosophila melanogaster
Vonesch, S. C., Lamparter, D., Mackay, T. F. C., Bergmann, S., & Hafen, E. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005616 · Cited by 63
“Larger genome regions and not single genes are mapped; uncontrolled environmental variability makes it difficult to identify causal links between genotype and phenotype; and functional validation cannot be performed in humans (12,16,33,34,35).”
BackgroundRevealing the genetic basis of multiple sclerosis: are we there yet?
Baranzini, S. E. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.12.006 · Cited by 80
“2 [50,51] thus practically guaranteeing identification of the complete set of common variants involved in MS.”
Self-citationCaminero, A. B., Comabella, M., & Montalbán, X. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04484.x · Cited by 58
Genome-wide approaches to schizophrenia
Duan, J., Sanders, A. R., & Gejman, P. V. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.04.009 · Cited by 53
“[15].”
Mohme, M., Hotz, C., Stevanović, S., Binder, T., Lee, J.-H., Okoniewski, M., Eiermann, T., Sospedra, M., Rammensee, H.-G., & Martin, R. (2013) · Brain · doi:10.1093/brain/awt108 · Cited by 53
“The association between human leucocyte antigen (HLA)-DR15 (formerly called DR2) and multiple sclerosis was first noticed in 1973 (Jersild et al., 1973), and since then has been among the most reproduced findings in major histocompatibility complex (MHC) genetics (Oksenberg et al., 2008).”
Backgroundde Mendizábal, N. V., Carneiro, J., Solé, R. V., Goñi, J., Bragard, J. R., Martínez‐Forero, I., Martinez‐Pasamar, S., Sepulcre, J., Torrealdea, J., Bagnato, F. R., et al. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-114 · Cited by 59
“HLA class II susceptibility alleles (DRB1*1501), IL2R or IL7R for MS) [48], in conjunction with the shaping of the immune repertoire during ontogeny and the presence of stochastic infectious challenges for generating individuals susceptible to develop autoimmune diseases.”
BackgroundMicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis
Severin, M. E., Lee, P. W., Liu, Y., Selhorst, A. J., Gormley, M. G., Pei, W., Yang, Y., Guerau-de-Arellano, M., Racke, M. K., & Lovett-Racke, A. E. (2016) · Brain · doi:10.1093/brain/aww084 · Cited by 52
“environmental and genetic factors in multiple sclerosis susceptibility (Hafler et al., 2007; Ebers, 2008; Oksenberg et al., 2008; Baranzini et al., 2009a).”
BackgroundHLA-B7–Restricted EBV-Specific CD8+ T Cells Are Dysregulated in Multiple Sclerosis
Jilek, S., Schluep, M., Harari, A., Canales, M., Lysandropoulos, A. P., Ζεκερίδου, Α., Pantaleo, G., & Pasquier, R. D. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103100 · Cited by 50
“E nvironmental and genetic factors are both thought to be involved in thepathogenesisofmultiple sclerosis (MS) (1, 2).”
BackgroundModulation of multiple sclerosis by sunlight exposure: Role of cis-urocanic acid
Correale, J., & Farez, M. F. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.05.014 · Cited by 47
“Although disease etiology remains elusive, both environmental and genetic factors are believed to play a role in MS development (Oksenberg et al., 2008; Pugliatti et al., 2008).”
Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis
Jadidi‐Niaragh, F., & Mirshafiey, A. (2011) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2010.513391 · Cited by 49
“Among the various etiological factors for MS, it appears that the genetic factors are most prominent for susceptibility to MS.((13)) Several genes are suggested in connection with progression or susceptibility to MS, including genes related to hexose-6-phosphate dehydrogenase,((14)) interferon regulatory factor 5 (IRF…”
BackgroundThe impact of environmental infections (parasites) on MS activity
Correale, J. D., & Farez, M. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511418027 · Cited by 46
“The genetic component of MS is believed to result from common allelic variants in several genes.(2) Some loci may be involved in early pathogenic events, while others could influence disease development and progression.”
BackgroundYeshokumar, A. K., Narula, S., & Banwell, B. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000452 · Cited by 61
The Evi5 family in cellular physiology and pathology
Lim, Y. S., & Tang, B. L. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.04.036 · Cited by 51
“MS has a modest degree of heritability, and the Human Leukocyte Antigen (HLA) region is a known strong susceptibility locus for MS [80].”
Background
Metadata
- Authors
- Oksenberg, J. R., Baranzini, S. E., Sawcer, S., & Hauser, S. L.
- Affiliations
- University of California, San Francisco (US)
- University of Cambridge (GB)
- Corresponding author
- Oksenberg, Jorge R.
- Hauser, Stephen L.
- Venue
- Nature Reviews Genetics
- Published
- 2008-06-10
- Volume
- 9
- Issue
- 7
- Pages
- 516-526
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- OpenAlex
- W1991500494
- Cited by
- 347
- References
- 125
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 5 · 2023: 12 · 2022: 8 · 2021: 7 · 2020: 11 · 2019: 7 · 2018: 10 · 2017: 15 · 2016: 15 · 2015: 22 · 2014: 27 · 2013: 20 · 2012: 22
- FWCI
- 5.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- multiple sclerosis, genetic susceptibility, single nucleotide polymorphisms, genome-wide association study, HLA region, gene-environment interaction, autoimmune demyelinating disease, pathogenesis, susceptibility genes, neuroimaging
- MeSH terms
- Animals, HLA Antigens, Humans, Multiple Sclerosis, Genome, Human, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.